NCT01464931View on ClinicalTrials.gov

Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2013

Conditions
Renal Impairment
Interventions
DRUG

Denosumab

Adminstered by subcutaneous injection

Trial Locations (7)

29118

Research Site, Orangeburg

33028

Research Site, Pembroke Pines

48236

Research Site, Detroit

78215

Research Site, San Antonio

80230

Research Site, Denver

83642

Research Site, Meridian

85284

Research Site, Tempe

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT01464931 - Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis | Biotech Hunter | Biotech Hunter